Clinical Trials Directory

Trials / Completed

CompletedNCT02603783

Esophageal capsaïcin Infusion and Mucosal Integrity

"Effect of capsaïcin Infusion on Esophageal Mucosal Integrity - a Role for TRPV1-mediated Neuropeptides?"

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Reflux is common, especially after large meals. In general, this can do no harm. However, if reflux occurs often and causes troublesome symptoms and or complications, it is called gastroesophageal reflux disease (GERD). Long exposure to gastric acid causes the mucosa of the esophagus to loose its integrity, which is thought to lead to the symptom of heartburn. Several food products can also impair the esophageal mucosa integrity and thereby influence reflux symptoms. One of these products is capsaicin, the pungent ingredient of red peppers. Use of capsaicin often leads to worsening of complaints in patients with GERD and can cause symptoms in healthy volunteers, possibly due to its effect on the mucosal integrity. In this study the investigators want to investigate the effect of capsaicin infusion on mucosal integrity. The investigators will evaluate mucosal impedance and the histology of the esophageal mucosa. In addition, the investigators also aim to assess the involvement of the TRPV1 receptor by evaluating the possible release of neuropeptides in the esophageal mucosa.

Conditions

Interventions

TypeNameDescription
OTHERCapsaicincapsaicin 1,5 mg
OTHERPlacebo0,9% saline 75 ml

Timeline

Start date
2015-11-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2015-11-13
Last updated
2017-05-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02603783. Inclusion in this directory is not an endorsement.